More on BCAX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.2 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Bicara Therapeutics (NQ:BCAX)
Delayed: 23.18 -0.46 (1.95%)
Prev. Close $23.64  
Open$23.31 
52 Wk High$ 
52 Wk Low$ 
Day High$23.63 
Day Low$22.50 
P/E N/A  
EPS$ 
Volume437,418 

Friends, Peers and Foes (?): AMGN, BBIO, ARGX, JNJ, IOBT (more...)

Sep 10, 2026 09:27 AM Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
Sep 3, 2026 08:30 AM Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Aug 25, 2026 04:58 PM Form 8-K Bicara Therapeutics Inc. For: Aug 21
Aug 21, 2026 04:04 AM Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens as Pivotal Trial Advances
Aug 18, 2026 04:13 PM BMO Capital Starts Bicara Therapeutics Inc (BCAX) at Outperform
Aug 14, 2026 04:55 PM Form 4 Bicara Therapeutics Inc. For: Aug 12 Filed by: Larson Jennifer
Aug 14, 2026 04:54 PM Form 3 Bicara Therapeutics Inc. For: Aug 12 Filed by: Larson Jennifer
Aug 14, 2026 08:30 AM Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Aug 13, 2026 12:42 PM Form SCHEDULE 13G/A Bicara Therapeutics Inc. Filed by: Janus Henderson Group Ltd.
Aug 12, 2026 04:19 PM Form 4 Bicara Therapeutics Inc. For: Aug 10 Filed by: Hyep Ivan
View All Articles

Entities mentioned with BCAX

View All Entities